Designing devices centered around patients is a goal espoused by nearly all device companies nowadays, as they aim to make products that people want to use and can incorporate into their everyday lives. Underscoring those products is often years of research and some in the industry have begun to think about how a patient’s needs […]
Research & Development
Study: West’s device aids in dose-sparing administration of polio vaccine
West Pharmaceutical Services (NYSE:WST) touted results today from a study showing that its ID Adapter can improve the intradermal administration of polio vaccines. The study, published in the journal Vaccine, evaluated the feasibility of using a fractional inactivated polio virus vaccine in remote locations where polio outbreaks continue to be of serious concern to public health […]
pSivida and Nicox partner to develop sustained-release IOP drug for glaucoma patients
pSivida (NSDQ:PSDV) and Nicox (EPA:COX) said today that the companies are collaborating to develop a sustained-release drug to lower intraocular pressure in people with glaucoma or ocular hypertension. The deal combines pSivida’s bioerodible sustained-release drug delivery system with Nicox’s nitric oxide-donating compounds. According to the agreement, pSivida is responsible for initial development activities. Nicox is slated […]
Smart bandage releases medication as needed
A team of researchers from the University of Nebraska, Harvard Medical School and MIT have created a smart bandage that can be loaded with antibiotics, painkillers or other drugs and triggered by a smartphone. The bandage, made of electrically conductive fibers individually coated in a drug-loaded hydrogel, could be used to deliver multiple drugs at […]
Medtech stories we missed this week: Oct. 6, 2017
From Intellijoint’s CE Mark to Patrona Medical and Kopis new partnership, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Intellijoint CE Mark for flagship hip navigation Intellijoint surgical announced in an Oct. 4 press release that it has received CE Mark for its Intellijoint HIP System in […]
Nanopatch tops needles, syringes as delivery system for polio vaccine in animal study
A microscopic vaccine delivery platform developed by researchers at the University of Queensland has proven a more effective way to deliver a polio virus vaccine compared to needles and syringes in an animal model. “Polio was one of the most dreaded childhood diseases of the 20th century, resulting in limb disfigurement and irreversible paralysis in […]
Inovio touts first-in-man Ph1 trial of Zika virus vaccine
Inovio Pharmaceuticals (NSDQ:INO) touted today positive safety and immune response data from the first-in-man Phase I trial of its vaccine against the Zika virus. The trial showed that Inovio’s DNA-based vaccine triggered high levels of binding antibodies in all 40 participants. The team also reported observing a strong neutralizing antibody and T-cell immune response in vaccinated […]
Pavmed to drop 510(k), pursue de novo pathway for PortIO infusion system
Pavmed Inc. (NSDQ:PAVM) plans to drop the 510(k) application for its PortIO intraosseous infusion system and instead pursue a de novo pathway for its device, according to a document the company filed with the SEC yesterday. The move is based on a recommendation from the FDA, the company said. The company’s 510(k) relied upon substantial equivalence […]
Drug printing tech could enable pharmacies to make custom medications
Researchers at the University of Michigan have devised a way to print precise, pure doses of drugs onto a dissolvable strip, microneedle patch or dosing device, according to a study published in Nature Communications. The technology could one day allow pharmacies and hospitals to print custom-dosed medications for patients and boost drug development among researchers, the […]
PnuVax lands $29m grant for pneumonia vaccine
PnuVax said this week that it landed a $29.4 million grant from the Bill & Melinda Gates Foundation to develop and test its pneumococcal conjugate vaccine. The company is slated to receive milestone payments over the next three years as its vaccine moves through development and into proof-of-concept clinical trials. PnuVax’s product is designed to […]
